ALBANO, AURORA
 Distribuzione geografica
Continente #
AS - Asia 1.203
EU - Europa 948
NA - Nord America 860
SA - Sud America 173
AF - Africa 72
OC - Oceania 6
Totale 3.262
Nazione #
US - Stati Uniti d'America 805
IT - Italia 477
SG - Singapore 359
CN - Cina 247
VN - Vietnam 161
BR - Brasile 130
DE - Germania 119
HK - Hong Kong 102
IN - India 72
FR - Francia 66
FI - Finlandia 63
GB - Regno Unito 53
KR - Corea 46
JP - Giappone 44
RU - Federazione Russa 40
EG - Egitto 31
CA - Canada 28
BY - Bielorussia 21
TH - Thailandia 20
IL - Israele 19
NL - Olanda 19
ZA - Sudafrica 19
TR - Turchia 17
MY - Malesia 16
AR - Argentina 15
ID - Indonesia 15
MX - Messico 14
ES - Italia 13
HU - Ungheria 13
IQ - Iraq 13
BD - Bangladesh 12
TW - Taiwan 12
AT - Austria 10
PK - Pakistan 9
PL - Polonia 9
SA - Arabia Saudita 9
MA - Marocco 7
PT - Portogallo 7
UA - Ucraina 7
CY - Cipro 6
PH - Filippine 6
VE - Venezuela 6
AL - Albania 5
CH - Svizzera 5
GR - Grecia 5
JO - Giordania 5
PY - Paraguay 5
AU - Australia 4
CL - Cile 4
CO - Colombia 4
DZ - Algeria 4
EC - Ecuador 4
DO - Repubblica Dominicana 3
JM - Giamaica 3
NO - Norvegia 3
NP - Nepal 3
PE - Perù 3
SE - Svezia 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
BE - Belgio 2
CZ - Repubblica Ceca 2
IE - Irlanda 2
KE - Kenya 2
MO - Macao, regione amministrativa speciale della Cina 2
NG - Nigeria 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
ET - Etiopia 1
GD - Grenada 1
IR - Iran 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
ML - Mali 1
MM - Myanmar 1
NC - Nuova Caledonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RO - Romania 1
RS - Serbia 1
SV - El Salvador 1
TG - Togo 1
UY - Uruguay 1
Totale 3.262
Città #
Rome 202
Singapore 202
Dallas 111
San Jose 111
Hong Kong 86
Ashburn 71
Munich 64
Santa Clara 62
The Dalles 53
Hanoi 48
Turku 44
Ho Chi Minh City 39
Los Angeles 39
Tokyo 37
Boardman 28
Beijing 27
Lauterbourg 25
Moscow 23
Bangkok 20
Milan 20
Minsk 20
Al Mansurah 17
New York 16
Nuremberg 16
São Paulo 16
Florence 15
Hefei 15
Helsinki 15
Naples 14
Johannesburg 13
Buffalo 12
Frankfurt am Main 12
Kuala Lumpur 12
Parma 12
Jefferson 11
Jerusalem 11
Falkenstein 10
Guangzhou 10
Haiphong 10
London 10
Seoul 10
Camden 9
Incheon 9
Redondo Beach 9
Ulsan 9
Vitorchiano 9
Atlanta 8
Budapest 8
Jakarta 8
Toronto 8
Vienna 8
Cairo 7
Hillsboro 7
Messina 7
Shanghai 7
Baghdad 6
Chapel Hill 6
Da Nang 6
Dhaka 6
Limassol 6
Pescara 6
Shenzhen 6
Warsaw 6
Amsterdam 5
Bedford 5
Chicago 5
Cosenza 5
Hải Dương 5
Lisbon 5
Marino 5
Mumbai 5
New Delhi 5
Orem 5
Palo Alto 5
Porto Alegre 5
Riyadh 5
Bengaluru 4
Bexley 4
Brasília 4
Brooklyn 4
Chandīgarh 4
City of London 4
Denver 4
Durham 4
Edmonton 4
Ferrara 4
Gainesville 4
Gwangju 4
Kaohsiung 4
Katwijk aan Zee 4
Kuala Selangor 4
Madrid 4
Mainz 4
Miami 4
Montreal 4
Nottingham 4
São Carlos 4
Tel Aviv 4
Thái Bình 4
Tianjin 4
Totale 1.911
Nome #
New Thiazolidine-4-One Derivatives as SARS-CoV-2 Main Protease Inhibitors 189
Targeting protein disulfide isomerase A with newly designed and synthesized aryl derivatives 168
Different approaches to target SARS-CoV-2: discovery of new small molecules as antiviral agents. 166
Discovery of small molecule derivatives as SARS-CoV-2 nsp13 inhibitors: a new strategy to develop broad-spectrum antiviral agents 157
Design and synthesis of novel compounds targeting both AURKA and HDAC enzymes. 149
Design and synthesis of new aryl derivatives as inhibitors of protein disulfide isomerase 139
From iloperidone to new sigma-1 receptor agonists using a structure-based approach. 138
Pyrrole derivatives targeting the Endocannabinoid System (ECS) in Prostate Cancer Cells 133
Identification of novel pyrimidine-based compounds as SARS-CoV-2 RNA-dependent RNA polymerase inhibitors. 130
Identification of new heterocyclic compounds as protein disulfide isomerase A inhibitors. 126
DEVELOPING NOVEL COMPOUNDS TARGETING AURKA AND HDAC ENZYMES SIMULTANEOUSLY 124
Design of New Sigma1 Agonists: a Structure-Based Approach for Huntington’s Disease Treatment. 122
Indolyl derivatives as SARS-CoV-2 nsp13 inhibitors active against viral replication 121
From iloperidone to new sigma-1 receptors agonists: a structure-based approach. 119
Structure-activity relationships of indolyl derivatives as SARS-CoV-2 nsp13 inhibitors 119
Structure-Based Drug Design Of New Sigma-1 Receptor Agonists 117
Structure-based drug design of new sigma-1 receptor agonists. 115
New nitrogen based derivatives as SARS-CoV-2 nsp13 inhibitors 109
Structure−Activity Relationships of New 1-Aryl-1H-Indole Derivatives as SARS-CoV-2 Nsp13 Inhibitors 108
New quinolinonyl derivatives as SARS-CoV-2 nsp13 inhibitors 106
Quinolinonyl Derivatives as Dual Inhibitors of the HIV-1 Integrase Catalytic Site and Integrase-RNA interactions 106
Nitrogen-based derivatives as RNA-dependent RNA polymerase inhibitors of SARS-CoV-2. 105
Inhibitors of protein-protein interaction between the human receptor ACE2 and the viral protein spike: a new frontier in the fight against SARS-CoV-2. 96
Unvealing newly discovered small molecules as ACE2-spike inhibitors against SARS-CoV-2. 94
NEW THIAZOLIDINE-4-ONE DERIVATIVES CAPABLE OF INHIBITING SARS-CoV-2 MPRO 89
UNCOVERING OF A PHARMACOPHORE MODEL FOR NITROGEN-ENRICHED MPRO INHIBITORS OF SARS-CoV-2 57
N-alkyl and N-benzyl indoles are anti-SARS-CoV-2 agents and nsp13 inhibitors 54
UNVEILING OF PHARMACOPHORE MODELLING FOR NITROGEN-ENRICHED MPRO INHIBITORS OF SARS-COV-2 45
Discovery of New SARS-CoV-2 Mpro Inhibitors Endowed with Nitrogen-based Scaffold 38
Totale 3.339
Categoria #
all - tutte 6.867
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.867


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.251 7 5 18 6 339 107 105 101 137 94 84 248
2025/20262.088 157 163 229 204 218 153 373 124 248 158 61 0
Totale 3.339